Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Series D brings in $43.6mm for AqueSys

Executive Summary

Ophthalmic device developer AqueSys Inc. raised $43.6mm through its Series D venture round. A new undisclosed investor led and was joined by current backers Accuitive Medical Ventures, the Carlyle Group, Longitude Capital, Rho Ventures, and SV Life Sciences. AqueSys, which developed the XEN gel stent for glaucoma, recently finished enrollment in its first IDE study, started enrollment of a study using another model, and began international commercialization of the device.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies